Profil
Heather Harte-Hall currently works at Society of Corporate Compliance & Ethics, as Member and Cabaletta Bio, Inc., as Chief Compliance Officer from 2021.
Ms. Harte-Hall also formerly worked at Adaptimmune Therapeutics Plc, as Head-Clinical Quality & Compliance.
Ms. Harte-Hall received her undergraduate degree from Saint Leo University, Inc. and graduate degree from Capella University LLC.
Postes actifs de Heather Harte-Hall
| Sociétés | Poste | Début |
|---|---|---|
| CABALETTA BIO, INC. | Compliance Officer | 01/03/2019 |
Society of Corporate Compliance & Ethics
Society of Corporate Compliance & Ethics Miscellaneous Commercial ServicesCommercial Services Provide training, certification, networking, and other resources to compliance officers & staff | Corporate Officer/Principal | - |
Anciens postes connus de Heather Harte-Hall
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Compliance Officer | - |
Formation de Heather Harte-Hall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Society of Corporate Compliance & Ethics
Society of Corporate Compliance & Ethics Miscellaneous Commercial ServicesCommercial Services Provide training, certification, networking, and other resources to compliance officers & staff | Commercial Services |
Saint Leo University, Inc.
Saint Leo University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Capella University LLC
Capella University LLC Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Cabaletta Bio, Inc.
Cabaletta Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which discovers and develops engineered cell therapies for B cell-mediated autoimmune diseases | Health Technology |
















